THOP1 and early-onset autosomal dominant Alzheimer disease: Three of those pathways specifically the LXR/RXR activation, neuroprotective role for THOP1 in Alzheimer’s disease, and glutamate receptor signaling pathways, shift from being up- to mostly downregulated as approaching advanced cancer stage III.